<qa>  How many participants each for the TAK-385 40 mg group or placebo group?Participants must be diagnosed to have uterine fibroids confirmed by transvaginal ultrasound or other methods. Participants must experience pain symptoms associated with uterine fibroids eg, lower abdominal pain and low back pain. The total number of participants to be randomized under double-blind conditions is 64 32 participants each for the TAK-385 40 mg group or placebo group. 